Literature DB >> 10395817

Processing of the N termini of nascent polypeptide chains requires deformylation prior to methionine removal.

J Solbiati1, A Chapman-Smith, J L Miller, C G Miller, J E Cronan.   

Abstract

N-formyl-methionine termini are formed in the initiation reaction of bacterial protein synthesis and processed during elongation of the nascent polypeptide chain. We report that the formyl group must be removed before the methionine residue can be cleaved by methionine aminopeptidase. This has long been implicitly assumed, but that assumption was based on inconclusive data and was in apparent conflict with more recently published data. We demonstrate that the Salmonella typhimurium methionine aminopeptidase is totally inactive on an N-formyl-methionyl peptide in vitro, and present a detailed characterization of the substrate specificity of this key enzyme by use of a very sensitive and quantitative assay. Finally, a reporter protein expressed in a strain lacking peptide deformylase was shown to retain the formyl group confirming the physiological role of the deformylase. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395817     DOI: 10.1006/jmbi.1999.2913

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  41 in total

1.  Application of high-precision isotope ratio monitoring mass spectrometry to identify the biosynthetic origins of proteins.

Authors:  I Apostol; P D Brooks; A J Mathews
Journal:  Protein Sci       Date:  2001-07       Impact factor: 6.725

2.  Omics Assisted N-terminal Proteoform and Protein Expression Profiling On Methionine Aminopeptidase 1 (MetAP1) Deletion.

Authors:  Veronique Jonckheere; Daria Fijałkowska; Petra Van Damme
Journal:  Mol Cell Proteomics       Date:  2018-01-09       Impact factor: 5.911

3.  A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy.

Authors:  Sang Joon Shin; Joong Bae Ahn; Kyung Soo Park; Yoon Jung Lee; Yong Sang Hong; Tae Won Kim; Hye Ryun Kim; Sun Young Rha; Jae Kyung Roh; Dal-Hyun Kim; Chin Kim; Hyun Cheol Chung
Journal:  Invest New Drugs       Date:  2010-12-29       Impact factor: 3.850

4.  Development and validation of a whole-cell inhibition assay for bacterial methionine aminopeptidase by surface-enhanced laser desorption ionization-time of flight mass spectrometry.

Authors:  Kenneth D Greis; Songtao Zhou; Richard Siehnel; Chuck Klanke; Alan Curnow; Jeremy Howard; Gerlinde Layh-Schmitt
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

5.  p21-activated kinase (Pak) regulates NADPH oxidase activation in human neutrophils.

Authors:  Kendra D Martyn; Moon-Ju Kim; Mark T Quinn; Mary C Dinauer; Ulla G Knaus
Journal:  Blood       Date:  2005-08-11       Impact factor: 22.113

6.  Escherichia coli peptidase A, B, or N can process translation inhibitor microcin C.

Authors:  Teymur Kazakov; Gaston H Vondenhoff; Kirill A Datsenko; Maria Novikova; Anastasia Metlitskaya; Barry L Wanner; Konstantin Severinov
Journal:  J Bacteriol       Date:  2008-01-25       Impact factor: 3.490

7.  Shine-Dalgarno interaction prevents incorporation of noncognate amino acids at the codon following the AUG.

Authors:  Viviana Di Giacco; Viter Márquez; Yan Qin; Markus Pech; Francisco J Triana-Alonso; Daniel N Wilson; Knud H Nierhaus
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-30       Impact factor: 11.205

8.  Dynamic enzyme docking to the ribosome coordinates N-terminal processing with polypeptide folding.

Authors:  Arzu Sandikci; Felix Gloge; Michael Martinez; Matthias P Mayer; Rebecca Wade; Bernd Bukau; Günter Kramer
Journal:  Nat Struct Mol Biol       Date:  2013-06-16       Impact factor: 15.369

9.  Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics.

Authors:  Mona D Lee; Yuhong She; Michael J Soskis; Christopher P Borella; Jeffrey R Gardner; Paula A Hayes; Benzon M Dy; Mark L Heaney; Mark R Philips; William G Bornmann; Francis M Sirotnak; David A Scheinberg
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

10.  NC2213: a novel methionine aminopeptidase 2 inhibitor in human colon cancer HT29 cells.

Authors:  Ponniah Selvakumar; Ashakumary Lakshmikuttyamma; Umashankar Das; Hari N Pati; Jonathan R Dimmock; Rajendra K Sharma
Journal:  Mol Cancer       Date:  2009-08-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.